Canadian Collaborative Research Network
Avatar

Stable CAD: ASA Alone, Prolonged DAPT or Low-Dose Rivaroxaban?

By Canadian Collaborative Research Network FEATURING Marc Sabatine
June 13, 2022
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
14:31
ARCH Advanced Revascularization Symposium

Updates on Pharmacology in the Cath Lab

Feat. J. Goetz
14:39
Lankenau

Management of AF patients with ACS

Feat. P. Kowey, D. Ice
28:11
Top Ten Topics in Clinical Cardiology 2021

Time to Retire Aspirin?

Feat. R. Mehran
15:40
ACC 2022 Conference Coverage

ACC 2022: Triple Therapy - When to Use and How Long

Feat. D. Kumbhani
11:26
Houston Methodist DeBakey Heart and Vascular Center

Aspirin for the Primary Prevention of Cardiovascular Disease: What C…

Feat. M. Miedema
21:51
Cedars Sinai

Treating Stenosis or Ischemia Does Not Improve Outcomes: Medical The…

Feat. W. Boden
19:47
Complex Coronary Cases

Therapy Post PCI: What Is the Rationale for DAPT and OAC? When to Us…

Feat. U. Baber
07:10
American College of Cardiology

Ticagrelor with or without Aspirin in ACS after PCI (TICO)

Feat. P. Block, Y. Jang
09:14
American College of Cardiology

MASTER DAPT: Dual Antiplatelet Therapy After PCI in Patients at High…

Feat. V. Fuster, D. Itchhaporia, M. Mack, C. Albert, J. Grapsa
12:46
AHA 2022 Conference Coverage

AHA 2022 Debate: Should CABG Be Level IIB for Improving Survival Com…

Feat. F. Bakaeen
57:30
McMaster University Department of Medicine

Five Things Every Internist Should Know About Anticoagulants

Feat. S. Mithoowani
17:49
CHEST 2022 Coverage

Perioperative Management of Antithrombotic Therapy

Feat. J. Douketis
20:50
Salim Virani

Aspirin for Primary Prevention

11:07
Houston Methodist DeBakey Heart and Vascular Center

Aspirin & Primary Prevention: What Do the Guidelines Say?

Feat. M. Gulati
14:20
ARCH Advanced Revascularization Symposium

Highlights and Critiques of ACC/AHA/SCAI Revascularization Guidelines

Feat. D. A. Cox
15:13
Cardiometabolic Health Congress (CMHC)

Dual Pathway Inhibition in the Cardiometabolic Patient: How Effectiv…

Feat. D. Bhatt
45:37
Cedars Sinai

Eliquis: Alternative Anticoagulation for HeartMate 3 Ventricular Ass…

Feat. M. Slaughter
13:36
Houston Methodist DeBakey Heart and Vascular Center

Plaque, Thrombosis and Bleeding Risk: Use of Antiplatelet Therapy

Feat. J. Ferreiro
37:35
Top Ten Topics in Clinical Cardiology 2022

Top 10 Coronary Interventional Trials of 2022

Feat. S. Sharma
08:07
Houston Methodist DeBakey Heart and Vascular Center

Anti Platelet Therapy Clinical Case Discussion: Q&A with Dr. Nea…

Feat. N. Kleiman